Found: 1
Select item for more details and to access through your institution.
RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 3, p. 336, doi. 10.3109/14397595.2015.1101200
- By:
- Publication type:
- Article